Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO^® (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior T

Menarini Hellas Α.Ε
Patmou 16-18
Marousi Attica
Ζip code 15123
Τel.: +30 210 8316111

• About Us
• History
• Products
• Menarini International

• Innovation & Research
• Careers
• News
• Fair Play Menarini

• Ethics and Compliance
• Contact Us
• Privacy

• Cookie Settings
• Pharmacovigilance
• Sitemap